Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2019

01-11-2019 | Hypersensitivity Pneumonitis | Original Article

NK and NKT-like cells in granulomatous and fibrotic lung diseases

Authors: L Bergantini, P Cameli, M d’Alessandro, C Vagaggini, RM Refini, C Landi, MG Pieroni, M Spalletti, P Sestini, E Bargagli

Published in: Clinical and Experimental Medicine | Issue 4/2019

Login to get access

Abtract

Background The pathogenetic and regulatory roles of natural killer (NK) and natural killer T-like cells in interstitial lung diseases (ILDs), fibrotic and granulomatous of unknown etiology are unclear. Objectives Here we investigated NK and NKT-like cells in peripheral blood (PB) and Bronchoalveolar lavage (BAL) from patients with ILDs. Method 190 patients (94 male mean age 61 ± 14.3 years) and 8 controls undergoing bronchoscopy for ILD diagnostic work-up were enrolled consecutively; 115 patients sarcoidosis, 24 chronic fibrotic hypersensitivity pneumonitis and 43 patients other ILDs [32 idiopathic pulmonary fibrosis (IPF) and 11 non-specific interstitial pneumonia (NSIP)]. PB and BAL were processed by flow cytometry using monoclonal antibodies to differentiate NK and NKT-like cells. Results NK% in BAL was significantly different among ILDs (p = 0.02). Lower NK% was observed in BAL from sarcoidosis than other ILDs (p < 0.05). Similar findings were observed for NKT-like, whereas no differences were found for PB NK%. Difference of NK% was observed between BAL and PB in all groups (p < 0.001). Sarcoidosis patients reported the best area under the curve for NKT-like (AUC = 0.678, p = 0.0015) and NK cells (AUC = 0.61, p = 0.001). In the IPF-NSIP subgroup, NK% cell was inversely correlated with FVC% (r = − 0.34, p = 0.03) and DLCO% (r = − 0.47, p = 0.0044). Conclusions NK and NKT-like were expressed differently in BAL from patients with different ILD and were significantly depleted in sarcoidosis respect to other ILDs. This suggests that these cells may play a protective role in the pathogenesis of sarcoidosis.
Appendix
Available only for authorised users
Literature
18.
go back to reference Souza-Fonseca-Guimaraes P, Guimaraes F, Natânia De Souza-Araujo C, et al. Natural killer cell assessment in peripheral circulation and bronchoalveolar lavage fluid of patients with severe sepsis: a case control study. Int J Mol Sci. 2017;18(3):1–2. https://doi.org/10.3390/ijms18030616.CrossRef Souza-Fonseca-Guimaraes P, Guimaraes F, Natânia De Souza-Araujo C, et al. Natural killer cell assessment in peripheral circulation and bronchoalveolar lavage fluid of patients with severe sepsis: a case control study. Int J Mol Sci. 2017;18(3):1–2. https://​doi.​org/​10.​3390/​ijms18030616.CrossRef
24.
go back to reference Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/European respiratory society/World association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 1999;16(2):149–73. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/European respiratory society/World association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG. 1999;16(2):149–73.
32.
go back to reference Agostini C, Trentin L, Zambello R, et al. Phenotypical and functional analysis of natural killer cells in sarcoidosis. Clin Immunol Immunopathol. 1985;37(2):262–75.CrossRefPubMed Agostini C, Trentin L, Zambello R, et al. Phenotypical and functional analysis of natural killer cells in sarcoidosis. Clin Immunol Immunopathol. 1985;37(2):262–75.CrossRefPubMed
Metadata
Title
NK and NKT-like cells in granulomatous and fibrotic lung diseases
Authors
L Bergantini
P Cameli
M d’Alessandro
C Vagaggini
RM Refini
C Landi
MG Pieroni
M Spalletti
P Sestini
E Bargagli
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 4/2019
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-019-00578-3

Other articles of this Issue 4/2019

Clinical and Experimental Medicine 4/2019 Go to the issue